Related Experiment Video
Updated: Feb 15, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1
Hui Gong1, Lishan Fang2, Yifan Li1
1Central Laboratory, Shenzhen Nanshan People's Hospital/Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, Guangdong 518033, P.R. China.
Abstract:
MicroRNA-873 (miR‑873) has been reported to be dysregulated in a variety of malignancies, however, the biological function and underlying molecular mechanism of miR‑873 in colorectal cancer (CRC) remain unclear. In the present study we found that the expression levels of miR‑873 were markedly decreased in CRC cell lines and tissues from patients. Statistical analysis revealed that miR‑873 expression was inversely correlated with the disease stage of CRC. Kaplan‑Meier survival analysis revealed that patients with CRC with lower miR‑873 expression had shorter overall survival rates. Additionally, downregulation of miR‑873 enhanced the proliferation of CRC cells, while upregulation of miR‑873 reduced this proliferation. Furthermore, we found that tumor necrosis factor (TNF) receptor-associated factor 5 (TRAF5) and TGF‑β activated kinase 1 (MAP3K7) binding protein 1 (TAB1) were direct targets of miR‑873 in CRC cells. A luciferase assay revealed that ectopic expression of miR‑873 significantly reduced nuclear factor κB (NF‑κB) luciferase activity, while ectopic expression of miR‑873 inhibitor enhanced luciferase activity, suggesting that downregulation of miR‑873 can activate NF‑κB signaling. Therefore, our findings established a tumor-suppressive role for miR‑873 in the inhibition of CRC progression, which may be employed as a novel prognostic marker and as an effective therapeutic target for CRC.
Insights
MicroRNA-873 (miR-873) is decreased in colorectal cancer (CRC), suppressing tumor growth. Lower miR-873 levels correlate with advanced CRC and poorer survival, indicating its potential as a prognostic marker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-873 (miR-873) dysregulation is noted in various cancers.
- The specific role and mechanism of miR-873 in colorectal cancer (CRC) are not well understood.
Purpose of the Study:
- To investigate the biological function and molecular mechanism of miR-873 in CRC.
- To determine if miR-873 can serve as a prognostic marker or therapeutic target for CRC.
Main Methods:
- Quantitative analysis of miR-873 expression in CRC cell lines and patient tissues.
- Correlation analysis between miR-873 levels and clinical parameters (disease stage, survival rates).
- Functional assays (proliferation) and molecular mechanism studies (luciferase assays, target validation).
Main Results:
- miR-873 expression was significantly reduced in CRC tissues and cell lines.
- Lower miR-873 expression correlated inversely with CRC disease stage and predicted shorter patient survival.
- miR-873 suppressed CRC cell proliferation by targeting tumor necrosis factor receptor-associated factor 5 (TRAF5) and MAP3K7 binding protein 1 (TAB1), thereby inhibiting nuclear factor κB (NF-κB) signaling.
Conclusions:
- miR-873 acts as a tumor suppressor in CRC progression.
- miR-873 holds potential as a novel prognostic biomarker and therapeutic target for colorectal cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Enzyme Inhibition
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

